Peyronie's disease

Urologic Clinics of North America

Volumn 28, Issue 2, 2001, Pages 377-390

  Gholami, Shahram S ^b   Lue, Tom F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOBENZOIC ACID; COLCHICINE; COLLAGENASE; DEXAMETHASONE; INTERFERON; SUPEROXIDE DISMUTASE; TAMOXIFEN; TRIAMCINOLONE; VERAPAMIL;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ERECTILE DYSFUNCTION; HISTOPATHOLOGY; HUMAN; INCIDENCE; IONTOPHORESIS; MALE; PATHOGENESIS; PEYRONIE DISEASE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

EID: 0034985508     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70146-4     Document Type: Article

References (108)

1. Is colchicine effective in Peyronie's disease? A pilot study
2. Colour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men
3. Radical surgery and conservation of erection in Peyronie's disease
4. Orgotein, a new drug for the treatment of Peyronie's disease
5. Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis
6. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro
7. Peyronie's disease: Cortisone-hyaluronidase-hydrocortisone therapy
8. Fibrous cavernositis: Further observation with report of 31 additional cases
9. Induratio penis plastica (Peyronie's disease): The results of the various forms of treatment
10. Induratio penis plastica: Clinical features and etiology
11. Penile prosthesis implantation in the treatment of Peyronie's disease
12. Potassium para-aminobenzoate for the treatment of Peyronie's disease: Is it effective?
13. Peyronie's disease: New concepts in etiology, diagnosis, and treatment
14. A case-control study on risk factors for Peyronie's disease
15. Factors associated in the aetiology of Peyronie's disease
16. Corporeal plication for surgical correction in Peyronie's disease improves rigidity
17. Ani-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts
18. Venogenic impotence following dermal graft repair for Peyronie's disease
19. The microscopic pathology of Peyronie's disease
20. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular desruptive drugs
21. Peyronie's disease
22. Surgical treatment of Peyronie's disease
23. Proposal: Trauma as the cause of the Peyronie's lesion
24. Outpatient assessment of penile curvature
25. Cellular and biochemical aspects of normal and abnormal wound healing: An overview
26. Correction of penile deformity assisted by intracavernous injection of papaverine
27. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasta by interferons alpha, beta, and gamma
28. New operation for "krummerik" (penile curvature)
29. Scar contracture: Cellular and connective tissue aspects in Peyronie's disease
30. Microtubules in transcellular movement of procollagen
31. Penile implants in the treatment of Peyronie's disease
32. Histological and ultrastructural alterations in an animal model of Peyronie's disease
33. An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression
34. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression
35. Venous patch graft for Peyronie's disease. Part II. Outcome analysis
36. New surgical treatment for Peyronie disease
37. The ultrasonic treatment of Peyronie's disease
38. Peryonie's disease: A study of its natural history and treatment with orthovoltage radiotherapy
39. Plaque-associated corporal veno-occlusive dysfunction in idiopathetic Peyronie's disease: A pharmacocavernosomatic and pharmacocavernosographic study
40. Peyronie curvature treated by plication of the penile fasciae
41. Dystrophic penile calcification in Peyronie's disease
42. The natural history of Peyroneis' disease
43. Expanding contractures of the tunica albuginea due to Peyronie's disease with temporalis fascia free grafts
44. Collagenase versus placebo in the treatment of Peronie's disease: A double-blind study
45. Peyronie's disease: Experience of local treatment with Orgotein
46. Effects of colchicine on collagenase in culture of rheumatoid synovium
47. Treatment of Peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)
48. Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction
49. Preoperative evaluation of erectile function with dynamic cavernosometry/cavernosography in patients undergoing surgery for Peyronie's disease: Survey of 50 patients
50. Intralesional interferon in the treatment of Peyronie's disease: In a pilot study
51. Interferon-alpha and interferon-gamma reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture
52. Classification of congenital and acquired penile deviation
53. Congenital penile deviation and its treatment with the Nesbit-Kelami technique
54. Congenital and acquired curvature of the penis treated surgically by plication of the tunica albuginea
55. Management of Peyronie's disease by implantation of inflatable penile prosthesis
56. Calcium antagonists retard extracellular matrix production in connective tissue equivalent
57. Is there an immunogenetic basis for Peyronie's disease?
58. Nesbit's operation for Peyronie's disease
59. Treatment of Peyronie's disease with intralesional verapamil injection
60. Penile vascular assessment using color duplex sonography
61. Intralesional verapamil injection for the treatment of Peyronie's disease
62. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984
63. Modified Nesbit procedure for the treatment of Peyronie's disease: A comparative outcome analysis
64. Penile vascular evaluation of men with Peyronie's disease
65. An operation for the cure of certain cases of plastic induration (Peyronie's disease) of the penis
66. Venous patch graft for Peyronie's disease. Part I. Technique
67. Peyronie's disease
68. Peyronie's disease is associated with Paget's disease of bone
69. A new method for treating Peyronie's disease
70. Vascular abnormalities in Peyronie's disease: The role of color Doppler sonography
71. AMS 3-piece inflatable penile prosthesis implantation in men with Peyronie's disease: Comparison of CX and Ultrex cylinders
72. Congenital curvature of the phallus: Report of three cases with description of corrective operation
73. Peyronie's disease and congenital penile curvature: Long-term results of operative treatment with the plication procedure
74. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens
75. Treatment of penile curvature - A retrospective study of 175 patients operated with plication of the tunica albuginea or with the Nesbit procedure
76. Congenital and acquired penile deviations and penile fractures
77. Orgotein in the treatment of plastic induration of the penis (Peyronie's disease)
78. The management of Peyronie's disease
79. Peryonie's disease and impotence
80. A new approach to the correction on the penile deformity in Peyronie's disease
81. The Nesbit operation for Peyronie's disease: 16-year experience
82. The treatment of Peyronie's disease with tamoxifen
83. Preoperative assessment of Peyronie's disease using colour Doppler sonography
84. The genetic and bacteriological aspects of Peyronie's disease
85. Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study
86. Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication)
87. 2+ channel blockers modulate metabolism of collagens within the extracellular matrix
88. Modified corporoplasty for penile curvature: 10 Years' experience
89. Prevalence of Peyronie's disease: Results of an 8000 men survey
90. Immunologic findings in Peyronie's disease: A controlled study
91. A new concept in the treatment of Peyronie's disease
92. Subclinical Peyronie's disease
93. Fibrin deposition in Peyronie's disease plaque
94. Evaluation of erectile dysfunction in patients with Peyronie's disease
95. Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease
96. Peyronie's disease: The new approach
97. Corporeal plication for surgical correction of penile curvature: Experience with 60 patients
98. Iontophoresis in the conservative treatment of Peyronie's disease: Preliminary experience
99. Mechanisms by which fibrin and fibronectin appear in healing wounds: Implications for Peyronie's disease
100. Nouveau traitment della maladie La Peyronie: La superoxyde desmutase par ionisiations. Comparison avec une serie ancienne clasique
101. Inflammatory and immunomodulatory roles of TGB-b
102. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease
103. The nonsurgical treatment of Peyronie's disease
104. The natural history of Peyronie's disease
105. A new treatment for Peyronie's disease: Modeling the penis over an inflatable penile prosthesis
106. Peyronie's disease: Results with dermojet injection of dexamethasone
107. Modified corporoplasty for the treatment of penile curvature
108. Treatment of Peyronie's disease with POTABA